Interleukin-6 regulates pancreatic α-cell mass expansion
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Interleukin-6 (IL-6) is systemically elevated in obesity and is a predictive factor to develop type 2 diabetes. Pancreatic islet pathology in type 2 diabetes is characterized by reduced β-cell function and mass, an increased proportion of α-cells relative to β-cells, and α-cell dysfunction. Here we show that the α cell is a primary target of IL-6 actions. Beginning with investigating the tissue-specific expression pattern of the IL-6 receptor (IL-6R) in both mice and rats, we find the highest expression of the IL-6R in the endocrine pancreas, with highest expression on the α-cell. The islet IL-6R is functional, and IL-6 acutely regulates both pro-glucagon mRNA and glucagon secretion in mouse and human islets, with no acute effect on insulin secretion. Furthermore, IL-6 stimulates α-cell proliferation, prevents apoptosis due to metabolic stress, and regulates α-cell mass in vivo . Using IL-6 KO mice fed a high-fat diet, we find that IL-6 is necessary for high-fat diet-induced increased α-cell mass, an effect that occurs early in response to diet change. Further, after high-fat diet feeding, IL-6 KO mice without expansion of α-cell mass display decreased fasting glucagon levels. However, despite these α-cell effects, high-fat feeding of IL-6 KO mice results in increased fed glycemia due to impaired insulin secretion, with unchanged insulin sensitivity and similar body weights. Thus, we conclude that IL-6 is necessary for the expansion of pancreatic α-cell mass in response to high-fat diet feeding, and we suggest that this expansion may be needed for functional β-cell compensation to increased metabolic demand.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interleukin (IL)-6, which is both an adipokine and myokine,287 was shown to influence the pancreas by controlling the expression of pro-glucagon mRNA as well as glucagon secretion. It also increases α-cell proliferation and islet mass while protecting the pancreas from metabolic stress-induced apoptosis.288”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [288]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Self-citationLiver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538 · cited 1×
“Upon IL-6 binding to its receptor, the IL-6R forms a complex with the signal transducing transmembrane glycoprotein, gp130, and signals are transduced via activation of STAT3 and ERK signaling, regulating downstream targets such as c-myc and bcl-2 (7, 13, 14).”
BackgroundInflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 2×
“IL-6 KO mice are known to become obese and glucose intolerant after 6–9 months of age due to lack of IL-6 central nervous system effects (10).”
BackgroundAdvances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes
Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 783
Self-citation共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値
Whittaker, P. G., Morgan, M. R., Dean, P., Cameron, E., & Lind, T. (1980) · The Lancet · Cited by 724
IL-6 signal transduction and its physiological roles: the signal orchestration model
Kamimura, D., Ishihara, K., & Hirano, T. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0012-2 · Cited by 673 · cited 5×
“Since gp130 is ubiquitously expressed, specificity of IL-6R signaling is mainly mediated by tissue specific IL-6R expression, and/or the local action of soluble IL-6Rs (7).”
BackgroundInfluentialEvidence that interleukin-6 is produced in human skeletal muscle during prolonged running
Ostrowski, K., Rohde, T., Zacho, M., Asp, S., & Pedersen, B. K. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.949bp.x · Cited by 673 · cited 2×
“Proc Natl Acad Sci USA 104(8):2861–2866.”
Background
Research works printed but not linked: 1
- Winzell MS, Ahren J, Renstrom E, Ahren B. Beta cell specific overexpression of glucagon receptors results in improved insulin secretion in response to glucose but impaired response to glucagon. Diabetologia. 2007;50:S28. [Google Scholar]
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“Islet GLP-1 production is also mediated by the cytokine IL-6, which is released in response to exercise, obesity and diabetes [163,164].”
BackgroundMuscle–Organ Crosstalk: The Emerging Roles of Myokines
Severinsen, M. C. K., & Pedersen, B. K. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa016 · Cited by 1,226
“It has clearly been shown that IL‐6 positively regulates β‐cell mass in vivo by stimulating β‐cell proliferation and preventing apoptosis induced by metabolic stress (191).”
BackgroundChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922
Self-citationIL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Taniguchi, K., & Karin, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.001 · Cited by 716
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571731 · Cited by 673
“Indeed, IL-6 knock out in obese mice inhibited the expansion of alpha cells, accompanied by reduced glucose stimulated insulin secretion (GSIS) (91).”
BackgroundAnti-inflammatory effects of exercise: role in diabetes and cardiovascular disease
Pedersen, B. K. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12781 · Cited by 617
Pedersen, B. K. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120033 · Cited by 516
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
Versatile functions for IL-6 in metabolism and cancer
Mauer, J., Denson, J. L., & Brüning, J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.008 · Cited by 407
Skeletal Muscle as an Endocrine Organ: The Role of Myokines in Exercise Adaptations
Hoffmann, C., & Weigert, C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029793 · Cited by 393
“Rodent studies provide evidence that IL-6 enhances expansion of pancreatic a cells (Ellingsgaard et al. 2008) and improves insulin secretion and hyperglycemia via stimulation of glucagen-like peptide 1 (GLP1) secretion from the L cells in the intestine and pancreatic a cells (Ellingsgaard et al.”
The role of interleukins in insulin resistance and type 2 diabetes mellitus
Fève, B., & Bastard, J.-P. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.62 · Cited by 343
Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity
Donath, M. Y., Dalmas, É., Sauter, N. S., & Böni-Schnetzler, M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.001 · Cited by 338
Self-citationIslet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes
Donath, M. Y., Böni-Schnetzler, M., Ellingsgaard, H., & Ehses, J. A. (2009) · Physiology · doi:10.1152/physiol.00032.2009 · Cited by 330
Self-citationBeyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J.-B., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 327
IL-6 signalling pathways and the development of type 2 diabetes
Akbari, M., & Hassan-Zadeh, V. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0458-0 · Cited by 302
Exercise and type 2 diabetes: focus on metabolism and inflammation
Karstoft, K., & Pedersen, B. K. (2016) · Immunology & Cell Biology · doi:10.1038/icb.2015.101 · Cited by 260
Rütti, S., Ehses, J. A., Sibler, R. A., Prazak, R., Rohrer, L., Georgopoulos, S., Meier, D. T., Niclauss, N., Berney, T., Donath, M. Y., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0252 · Cited by 237
Self-citationIL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling
Timper, K., Denson, J. L., Steculorum, S. M., Heilinger, C., Engström-Ruud, L., Wunderlich, C. M., Rose-John, S., Wunderlich, F. T., & Brüning, J. C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.043 · Cited by 233
Cytokine production by islets in health and diabetes: cellular origin, regulation and function
Donath, M. Y., Böni-Schnetzler, M., Ellingsgaard, H., Halban, P. A., & Ehses, J. A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.12.010 · Cited by 227
Self-citationEhses, J. A., Meier, D. T., Wueest, S., Rytka, J., Boller, S., Wielinga, P. Y., Schraenen, A., Lemaire, K., Debray, S., Van Lommel, L., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1747-3 · Cited by 222
“Brunswick, NJ, USA) as previously described [10, 23].”
MethodSelf-citationMyokines in insulin resistance and type 2 diabetes
Eckardt, K., Görgens, S. W., Raschke, S., & Eckel, J. (2014) · Diabetologia · doi:10.1007/s00125-014-3224-x · Cited by 221
Liver-Specific Disruption of the Murine Glucagon Receptor Produces α-Cell Hyperplasia
Longuet, C., Robledo, A. M., Dean, E. D., Dai, C., Ali, S., McGuinness, I., de Chavez, V., Vuguin, P. M., Charron, M. J., Powers, A. C., et al. (2013) · Diabetes · doi:10.2337/db11-1605 · Cited by 206
Garbers, C., Thaiss, W., Jones, G. W., Waetzig, G. H., Lorenzen, I., Guilhot, F., Lissilaa, R., Ferlin, W. G., Grötzinger, J., Jones, S. A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295758 · Cited by 191
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases
Hædersdal, S., Andersen, A., Knop, F. K., & Vilsbøll, T. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00817-4 · Cited by 176
GABA’s Control of Stem and Cancer Cell Proliferation in Adult Neural and Peripheral Niches
Young, S. Z., & Bordey, A. (2009) · Physiology · doi:10.1152/physiol.00002.2009 · Cited by 165
The physiology of optimizing health with a focus on exercise as medicine
Pedersen, B. K. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114339 · Cited by 163
Myokines mediate the cross talk between skeletal muscle and other organs
Chen, W., Wang, L., You, W., & Shan, T. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30033 · Cited by 162
“IL‐6 is necessary for the expansion of pancreatic α‐cell mass in response to HFD, and this expansion may be required for functional β‐cell compensation that leads to increasing metabolic demand (Ellingsgaard et al., 2008; Figure 5).”
BackgroundIL‐6 in diabetes and cardiovascular complications
Qu, D., Liu, J., Lau, C. W., & Huang, Y. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12713 · Cited by 159
Sachdeva, M. M., & Stoffers, D. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0400 · Cited by 158
Physiological effects of modulating the interleukin-6 axis
Schett, G. (2018) · Rheumatology · doi:10.1093/rheumatology/kex513 · Cited by 142
Beta cells in type 1 diabetes: mass and function; sleeping or dead?
Oram, R. A., Sims, E. K., & Evans‐Molina, C. (2019) · Diabetologia · doi:10.1007/s00125-019-4822-4 · Cited by 151
Interleukin-6 and interleukin-11: same same but different
Garbers, C., & Scheller, J. (2013) · bchm · doi:10.1515/hsz-2013-0166 · Cited by 134
Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states
El Ouaamari, A., Kawamori, D., Dirice, E., Liew, C. W., Shadrach, J. L., Hu, J., Katsuta, H., Hollister-Lock, J., Qian, W.-J., Wagers, A. J., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.007 · Cited by 136
Souza-Mello, V., Gregório, B. M., Cardoso-de-Lemos, F. S., de Carvalho, L., Aguila, M. B., & Mandarim-de-Lacerda, C. A. (2010) · Clinical Science · doi:10.1042/cs20100061 · Cited by 135
Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control
Lang Lehrskov, L., Lyngbaek, M. P., Soederlund, L., Legaard, G. E., Ehses, J. A., Heywood, S. E., Wewer Albrechtsen, N. J., Holst, J. J., Karstoft, K., Pedersen, B. K., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.008 · Cited by 135
Self-citationNąckiewicz, D., Dan, M., He, W., Kim, R., Salmi, A., Rütti, S., Westwell-Roper, C. Y., Cunningham, A. M., Speck, M., Schuster, C., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3249-1 · Cited by 133
Self-citationRepositioning Glucagon Action in the Physiology and Pharmacology of Diabetes
Finan, B., Capozzi, M. E., & Campbell, J. E. (2020) · Diabetes · doi:10.2337/dbi19-0004 · Cited by 118
Bouzakri, K., Plomgaard, P., Berney, T., Donath, M. Y., Pedersen, B. K., & Halban, P. A. (2011) · Diabetes · doi:10.2337/db10-1178 · Cited by 122
Self-citationTakeda, Y., Fujita, Y., Honjo, J., Yanagimachi, T., Sakagami, H., Takiyama, Y., Makino, Y., Abiko, A., Kieffer, T. J., & Haneda, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2365-4 · Cited by 126
“IL-6 stimulates alpha cell proliferation in a high-fat diet fed state with insulin resistance [44], and glucagon receptor knockout mice display alpha cell hyperplasia [45].”
BackgroundMuscle-Organ Crosstalk: Focus on Immunometabolism
Bay, M. L., & Pedersen, B. K. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.567881 · Cited by 109
Interleukin-6 Enhances Glucose-Stimulated Insulin Secretion From Pancreatic β-Cells
Suzuki, T., Imai, J., Yamada, T., Ishigaki, Y., Kaneko, K., Uno, K., Hasegawa, Y., Ishihara, H., Oka, Y., & Katagiri, H. (2011) · Diabetes · doi:10.2337/db10-0796 · Cited by 108
Traub, S., Meier, D. T., Schulze, F., Dror, E., Nordmann, T. M., Goetz, N., Koch, N., Dalmas, E., Stawiski, M., Makshana, V., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.005 · Cited by 116
Self-citationThe role of interleukin-6 in glucose homeostasis and lipid metabolism
Lehrskov, L. L., & Christensen, R. H. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00747-2 · Cited by 114
Why should people with type 1 diabetes exercise regularly?
Codella, R., Terruzzi, I., & Luzi, L. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0978-x · Cited by 122
Quintana, A., Erta, M., Ferrer, B., Comes, G., Giralt, M., & Hidalgo, J. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.10.011 · Cited by 120
Perrin, L., Loizides-Mangold, U., Skarupelova, S., Pulimeno, P., Chanon, S., Robert, M., Bouzakri, K., Modoux, C., Roux-Lombard, P., Vidal, H., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.009 · Cited by 104
Cytokines and Pancreatic β-Cell Apoptosis
Berchtold, L. A., Prause, M. C. B., Størling, J., & Mandrup-Poulsen, T. R. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.02.001 · Cited by 116
Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance
Wueest, S., Item, F., Lucchini, F. C., Challa, T. D., Müller, W., Blüher, M., & Konrad, D. (2016) · Diabetes · doi:10.2337/db15-0941 · Cited by 96
Interleukin 6 protects pancreatic β cells from apoptosis by stimulation of autophagy
Linnemann, A. K., Blumer, J. T., Marasco, M. R., Battiola, T. J., Umhoefer, H. M., Han, J. Y., Lamming, D. W., & Davis, D. B. (2017) · The FASEB Journal · doi:10.1096/fj.201700061rr · Cited by 110
“When these mice are fed ahigh-fatdiet theyhave impaireda-cell expansion and insulin secretion, leading to glucose intolerance (11).”
BackgroundA Primary Role for α-Cells as Amino Acid Sensors
Dean, E. D. (2019) · Diabetes · doi:10.2337/dbi19-0021 · Cited by 101
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao, R. Y., Tian, H., Zhang, Y., Liu, G., Xu, H., Rao, G., Tian, Y., & Fu, X. (2023) · MedComm · doi:10.1002/mco2.283 · Cited by 109
Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice
Millar, P., Pathak, N., Parthsarathy, V., Bjourson, A. J., O’Kane, M., Pathak, V., Moffett, R. C., Flatt, P. R., & Gault, V. A. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0263 · Cited by 102
Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction
Ehses, J. A., Ellingsgaard, H., Böni-Schnetzler, M., & Donath, M. Y. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903025879 · Cited by 97
Self-citationWhat role do fat cells play in pancreatic tissue?
Gerst, F., Wagner, R. J., Oquendo, M. B., Siegel-Axel, D. I., Fritsche, A., Heni, M., Staiger, H., Häring, H., & Ullrich, S. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.001 · Cited by 100
“In glucagon-secreting a-cells, IL-6 treatment increased proliferation [54,58].”
BackgroundBiological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers
Ho, L., Luo, S., & Lai, J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.009 · Cited by 96
Potential role of skeletal muscle glucose metabolism on the regulation of insulin secretion
Mizgier, M. L., Casas, M., Contreras‐Ferrat, A., Llanos, P., & Galgani, J. E. (2014) · Obesity Reviews · doi:10.1111/obr.12166 · Cited by 82
Glucagon's Metabolic Action in Health and Disease
Zeigerer, A., Sekar, R., Kleinert, M., Nason, S., Habegger, K. M., & Müller, T. D. (2021) · Comprehensive Physiology · doi:10.1002/cphy.c200013 · Cited by 59
The impact of anti-inflammatory cytokines on the pancreatic β-cell
Russell, M. A., & Morgan, N. G. (2014) · Islets · doi:10.4161/19382014.2014.950547 · Cited by 85
Hitting a complex target: an update on interleukin-6 trans-signalling
Waetzig, G. H., & Rose-John, S. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.660307 · Cited by 83
GLP-1 Effects on Islets: Hormonal, Neuronal, or Paracrine?
Donath, M. Y., & Burcelin, R. (2013) · Diabetes Care · doi:10.2337/dcs13-2015 · Cited by 79
Self-citationTargeting inflammation in diabetic kidney disease: early clinical trials
Perez-Gomez, M. V., Sanchez-Niño, M. D., Sanz, A. B., Zheng, B., Martín-Cleary, C., Ruiz-Ortega, M., Ortiz, A., & Fernandez-Fernandez, B. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1196184 · Cited by 78
α-cell role in β-cell generation and regeneration
Habener, J. F., & Stanojevic, V. (2012) · Islets · doi:10.4161/isl.20500 · Cited by 99
Exercise increases pancreatic β‐cell viability in a model of type 1 diabetes through IL‐6 signaling
Paula, F. M. M., Leite, N. C., Vanzela, E. C., Kurauti, M. A., Freitas‐Dias, R., Carneiro, E. M., Boschero, A. C., & Zoppi, C. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-264820 · Cited by 78
Westwell-Roper, C. Y., Nąckiewicz, D., Dan, M., & Ehses, J. A. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.4 · Cited by 75
Self-citationAbbondante, S., Eckel-Mahan, K. L., Ceglia, N. J., Baldi, P., & Sassone-Corsi, P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.681130 · Cited by 72
Lacraz, G., Giroix, M.-H., Kassis, N., Coulaud, J., Galinier, A., Noll, C., Cornut, M., Schmidlin, F., Paul, J., Janel, N., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006963 · Cited by 76
Self-citationKrause, M. D. S., Bock, P. M., Takahashi, H., de Bittencourt, P. I. H., & Newsholme, P. (2015) · Clinical Science · doi:10.1042/cs20140695 · Cited by 77
Soluble Factors Secreted by T Cells Promote β-Cell Proliferation
Dirice, E., Kahraman, S., Jiang, W., Ouaamari, A. E., Jesus, D. F. D., Teo, A. K. K., Hu, J. Y., Kawamori, D., Gaglia, J. L., Mathis, D. J., et al. (2013) · Diabetes · doi:10.2337/db13-0204 · Cited by 76
β‐cell mass in people with type 2 diabetes
Cho, J., Kim, J., Shin, J., Shin, J., & Yoon, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00072.x · Cited by 69
Szekeres, Z., Nagy, A., Jahner, K., & Szabados, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158214 · Cited by 78
“IL-6 has been The best-studied myokine is IL-6. vivo and prevent metabolic stress-induced IL-6 has been shown to stimulate β -cell proliferation in vivo and prevent metabolic stress-induced apoptosis [31]. stress-induced apoptosis [31].”
BackgroundHidalgo, J., Florit, S., Giralt, M., Ferrer, B., Keller, C., & Pilegaard, H. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.09.002 · Cited by 71
GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity
Amato, A., Baldassano, S., & Mulè, F. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0035 · Cited by 73
Anti-Inflammatory Properties of Exenatide in Human Pancreatic Islets
Cechin, S. R., Pérez-Álvarez, I., Fenjves, E., Molano, R. D., Pileggi, A., Berggren, P.-O., Ricordi, C., & Pastori, R. L. (2012) · Cell Transplantation · doi:10.3727/096368911x576027 · Cited by 67
Timper, K., Dalmas, E., Dror, E., Rütti, S., Thienel, C., Sauter, N. S., Bouzakri, K., Bédat, B., Pattou, F., Kerr-Conte, J., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.003 · Cited by 67
Self-citationInterleukin-6 contributes to early fasting-induced free fatty acid mobilization in mice
Wueest, S., Item, F., Boyle, C. N., Jirkof, P., Cesarovic, N., Ellingsgaard, H., Böni-Schnetzler, M., Timper, K., Arras, M., Donath, M. Y., et al. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00533.2013 · Cited by 60
Self-citationEffects of nicotine on homeostatic and hedonic components of food intake
Stojakovic, A., Espinosa, E. P., Farhad, O. T., & Lutfy, K. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0166 · Cited by 64
Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion
Holter, M. M., Saikia, M., & Cummings, B. P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.934775 · Cited by 63
Glucagon-Like Peptide-2 Receptor Modulates Islet Adaptation to Metabolic Stress in the ob/ob Mouse
Bahrami, J., Longuet, C., Baggio, L. L., Li, K., & Drucker, D. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.006 · Cited by 63
The potential role of glutamate in the current diabetes epidemic
Davalli, A. M., Perego, C., & Folli, F. B. (2012) · Acta Diabetologica · doi:10.1007/s00592-011-0364-z · Cited by 64
“IL6 is also a potent regulator of cellular proliferation [205], and the pancreatic a-cell is a primary target of IL6 function that increases glucagon secretion and stimulates a-cell proliferation [208].”
Otsuka, Y., Kiyohara, C., Kashiwado, Y., Sawabe, T., Nagano, S., Kimoto, Y., Ayano, M., Mitoma, H., Akahoshi, M., Arinobu, Y., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196368 · Cited by 62
Interleukin‐6 treatment induces beta‐cell apoptosis via STAT‐3‐mediated nitric oxide production
Oh, Y. S., Lee, Y. S., Park, E. Y., & Jun, H. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1233 · Cited by 63
Erlandsson, M. C., Silfverswärd, S. T., Nadali, M., Turkkila, M., Svensson, M. N. D., Jonsson, I., Andersson, K., & Bokarewa, M. I. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.002 · Cited by 65
Habener, J. F., & Stanojevic, V. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.10.009 · Cited by 62
Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes
Marroquí, L., Alonso-Magdalena, P., Merino, B., Fuentes, E., Nadal, A., & Quesada, I. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000031 · Cited by 54
“3 mM) combined with palmitate to simulate in vitro glucolipotoxicity conditions induce apoptosis in pancreatic a-cells((43)).”
BackgroundIL-6 and diabetic kidney disease
Zhang, L., Xu, F., & Hou, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1465625 · Cited by 57
Physical exercise in kidney disease: A commonly undervalued treatment modality
Kanbay, M., Çöpür, S., Yıldız, A. B., Tanrıöver, C., Mallamaci, F., & Zoccali, C. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14105 · Cited by 54
Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis
Linnemann, A. K., Neuman, J. C., Battiola, T. J., Wisinski, J. A., Kimple, M. E., & Davis, D. B. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1030 · Cited by 54
Glucagon‐Like Peptide‐1: Actions and Influence on Pancreatic Hormone Function
Davis, E., & Sandoval, D. A. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190025 · Cited by 60
New Insights Into the Role of Autoreactive CD8 T Cells and Cytokines in Human Type 1 Diabetes
Bender, C., Rajendran, S. H., & von Herrath, M. G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.606434 · Cited by 57
“Cytokines such as IL-6 act at a physiological level in islet cells to maintain glucose homeostasis (26), whereas other cytokines such as IFN-g and CXCL10 may play a pathogenic role by contributing to immune cell recruitment and beta-cell killing.”
BackgroundWeiss, H., Wester-Rosenloef, L., Koch, C., Koch, F., Baltrusch, S., Tiedge, M., & Ibrahim, S. (2012) · Endocrinology · doi:10.1210/en.2012-1296 · Cited by 52
Russell, M. A., Cooper, A. C., Dhayal, S., & Morgan, N. G. (2013) · Islets · doi:10.4161/isl.24249 · Cited by 54
Barbagallo, D., Piro, S., Condorelli, A. G., Mascali, L. G., Urbano, F., Parrinello, N. L., Monello, A., Statello, L., Ragusa, M., Rabuazzo, A. M., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-62 · Cited by 62
Trinh, B., Peletier, M., Simonsen, C., Plomgaard, P., Karstoft, K., Klarlund Pedersen, B., van Hall, G., & Ellingsgaard, H. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100396 · Cited by 42
Self-citationChrono-exercise: Time-of-day-dependent physiological responses to exercise
Kim, H., Radak, Z. O., Takahashi, M., Inami, T., & Shibata, S. (2022) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2022.11.003 · Cited by 53
TLR4 triggered complex inflammation in human pancreatic islets
He, W., Rebello, O. D., Savino, R., Terracciano, R., Schuster, C., Guardiola, B., & Maedler, K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.030 · Cited by 54
da Silva Krause, M., Bittencourt, A., Homem de Bittencourt, P. I., McClenaghan, N. H., Flatt, P. R., Murphy, C., & Newsholme, P. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0223 · Cited by 48
“…glucagon levels, and iii) evidence exists that high concentrations of IL6 directly regulate a- and b-cell function in the pancreatic islet (Ellingsgaard et al. 2008, 2011) while IL6 can promote insulin secretion via GLP1 release and subsequent b-cell action, we decided to investigate the…”
BackgroundResultOsto, M., Zini, E., Reusch, C. E., & Lutz, T. A. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.11.019 · Cited by 51
Adipose Tissue as an Endocrine Organ
Musi, N., & Guardado‐Mendoza, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408134-5.00014-7 · Cited by 69
Metadata
- Authors
- Ellingsgaard, H., Ehses, J. A., Hammar, E. B., Van Lommel, L., Quintens, R., Martens, G., Kerr-Conte, J., Pattou, F., Berney, T., Pipeleers, D., Halban, P. A., Schuit, F. C., & Donath, M. Y.
- Affiliations
- University Hospital Zurich (CH)
- University of Geneva (CH)
- Gene Expression Unit, Department of Molecular Cell Biology, Katholieke Universiteit Leuven, 3000 Leuven, Belgium;
- KU Leuven (BE)
- Diabetes Research Center, Brussels Free University, Laarbeeklaan 103, B-1090 Brussels, Belgium; and
- Inserm (FR)
- **Cell Therapy of Diabetes, ERIT-M 0106, Institut National de la Santé et de la Recherche Médicale, Faculty of Medicine, 1 Place de Verdun, 59045 Lille, France
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-02
- Volume
- 105
- Issue
- 35
- Pages
- 13163-13168
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2529061
- OpenAlex
- W2032658955
- Cited by
- 269
- References
- 40
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 21 · 2023: 22 · 2022: 11 · 2021: 16 · 2020: 13 · 2019: 19 · 2018: 14 · 2017: 12 · 2016: 14 · 2015: 22 · 2014: 18 · 2013: 23 · 2012: 17
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- interleukin-6, alpha cells, IL-6 receptor, glucagon secretion, alpha-cell proliferation, high-fat diet, type 2 diabetes, beta-cell compensation, insulin secretion, obesity, islets
- MeSH terms
- Animals, Dietary Fats, Feeding Behavior, Gene Expression Regulation, Glucagon, Glucose Tolerance Test, Humans, Male, Mice, Inbred C57BL, Phosphorylation, Protein Precursors, RNA, Messenger, Interleukin-6, Rats, Wistar, Apoptosis, Mice, Knockout, Receptors, Interleukin-6, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, STAT3 Transcription Factor, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.